Comparison |
Alternate Manufacturer Number |
2538726 | 3696549 | | | 2046720 |
Alternate Packaging |
| CT/10 | CT/10 | | CT/10 |
Container Type |
Single-Dose Vial | Single-Dose Vial | Prefilled Syringe | Cartridge | Single-Dose Vial |
Country of Origin |
United States | France | United States | United States | United States |
Generic Drug Code |
27095 | 17150 | 17142 | 45132 | 17142 |
Generic Drug Name |
Naltrexone Microspheres | Naloxone HCl, Preservative Free | Naloxone HCl, Preservative Free | Naloxone HCl, Preservative Free | Naloxone HCl, Preservative Free |
Latex Free Indicator |
| | | Not Made with Natural Rubber Latex | |
NDC Number |
65757030001 | 70069007110 | 76329336901 | 00409178269 | 76329146901 |
Quantity |
1 Kit | | | | |
Storage Requirements |
Requires Refrigeration | | | | |
Strength |
380 mg | 0.4 mg / mL | 1 mg / mL | 0.4 mg / mL | 1 mg / mL |
Type |
Intramuscular | Intramuscular, Intravenous, or Subcutaneous | Intramuscular, Intravenous, or Subcutaneous | Intramuscular, Intravenous, or Subcutaneous | Intramuscular, Intravenous, or Subcutaneous |
UNSPSC Code |
51142303 | 51142315 | 51142315 | 51142315 | 51142315 |
Volume |
| 1 mL | 2 mL | 1 mL | 2 mL |
Application |
Opiate Antagonist | Opiate Antagonist | Opiate Antagonist | Opiate Antagonist | Opiate Antagonist |
Dosage Form |
Injection | Injection | Injection | Injection | Injection |
Product Dating |
McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days |
Features and Benefits |
- Vivitrol* ER (naltrxone for extended-release injectable suspension) is to be administered by intramuscular injection
- The microspheres, diluent, preparation needle, and an administration needle with needle protection device are required for preparation and administration
- Two thin-walled 1.5-inch needles (20 gauge) with needle protection device and two 2-inch thin-walled needles (20 gauge) with needle protection device have been provided to accommodate varying patient body habitus
- Do not substitute any other components for the components of the carton
|
- Naloxone Hydrochloride Injection is indicated for the complete or partial reversal of opioid depression, including respiratory depression, induced by natural and synthetic opioids including methadone, and certain mixed agonist-antagonist analgesics: nalbuphine, pentazocine, butorphanol, and cyclazocine
- Naloxone hydrochloride is also indicated for the diagnosis of suspected or known acute opioid overdosage
- The single-dose solution contains no bacteriostat, antimicrobial agent or added buffer (except for pH adjustment) and is intended for use only as a single-dose injection
- Store at 20° to 25°C (68° to 77°F)
- Protect from light by retaining in the carton until ready for use
- Single-dose glass flip top vial
- 10 vials per carton
|
- Generic Equivalent to Narcan®; Evzio™
- Luer-Jet™ needleless syringe
- Color-coded packaging - industry standard color-coding to aid in quick, reliable identification
- Emergency Syringes provided in completely needleless Luer Lock syringes, complies with OSHA's Needlestick Safety and Prevention Act and are compatible with most Luer Activated Systems (includes ICU Medical Clave® Valve)
|
- 1 mL fill in 2.5 mL Carpuject™ Single-dose cartridge with Luer Lock for the Carpuject™ Syringe System
- All Carpuject™ Luer Lock Glass Syringe (no needle) products require the use of the Carpuject™ holder, list number 02049-02, for administration
|
|